GSK (LON:GSK) Insider Purchases £114.87 in Stock

GSK plc (LON:GSK) insider Emma Walmsley bought 7 shares of the stock in a transaction that occurred on Thursday, October 9th. The shares were purchased at an average cost of GBX 1,641 per share, with a total value of £114.87.

Emma Walmsley also recently made the following trade(s):

• On Tuesday, September 9th, Emma Walmsley bought 9 shares of GSK stock. The shares were purchased at an average cost of GBX 1,486 per share, with a total value of £133.74.
• On Monday, August 11th, Emma Walmsley purchased 9 shares of GSK stock. The shares were acquired at an average price of GBX 1,408 per share, with a total value of £126.72.

GSK Stock Performance

Shares of GSK stock opened at GBX 1,625 on Monday. The company has a current ratio of 0.81, a quick ratio of 0.73 and a debt-to-equity ratio of 114.64. The business has a 50-day moving average price of GBX 1,488.36 and a two-hundred day moving average price of GBX 1,438.82. GSK plc has a 1-year low of GBX 1,242.50 and a 1-year high of GBX 1,684.50. The company has a market cap of £65.40 billion, a P/E ratio of 1,964.93, a PEG ratio of 1.24 and a beta of 0.31.

GSK (LON:GSK) last announced its earnings results on Wednesday, July 30th. The company reported GBX 75.30 EPS for the quarter. GSK had a return on equity of 18.08% and a net margin of 8.02%. As a group, analysts anticipate that GSK plc will post 175.980975 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on GSK. Berenberg Bank reissued a “hold” rating and issued a GBX 1,600 price target on shares of GSK in a research note on Friday, July 18th. JPMorgan Chase & Co. reiterated an “under review” rating on shares of GSK in a research note on Friday, October 3rd. Shore Capital restated a “buy” rating and issued a GBX 2,100 price target on shares of GSK in a report on Wednesday, August 27th. Finally, Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a GBX 1,450 price target on shares of GSK in a report on Thursday, July 31st. One equities research analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of GBX 1,637.50.

About GSK

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D.